 |
|
London School of Hygiene to play key role in global collaboration on adverse drug reactions
September 27, 2007The London School of Hygiene & Tropical Medicine is to be a key player in the first global research collaboration aimed at identifying the genetic markers related to Adverse Drug Reactions (ADRs).
The Serious Adverse Event Consortium (SAEC) is a non-profit global partnership between leading pharmaceutical companies, drug regulatory authorities and academic institutions aimed at identifying genetic markers that may help to predict which patients are at risk from adverse or serious drug reactions (ADRs). It will provide a global knowledge base about these genetic variations and will be a major step forward in the drive to develop and deliver safer medicines.
ADRs are important causes of illness, limit the usefulness of many otherwise effective drugs, and are under strong genetic influence. Identifying the genetic variants that may influence a patient's susceptibility to ADRs will greatly improve our understanding of the risk and molecular basis of adverse drug reactions.
Dr. Mariam Molokhia, Clinical Lecturer at the London School of Hygiene & Tropical Medicine, will be one of the main UK investigators of the collaborative project, and will be working jointly with SAEC to address clinical and scientific issues and identify DNA-variants useful in predicting the risk of drug-related serious adverse events, including liver toxicity and other series ADRs.
Dr. Molokhia co-ordinates the EUDRAGENE project, a European collaboration to establish a case-control DNA collection for studying the genetic basis of adverse drug reactions. She comments: 'Research in this area is hampered by a lack of resources. As most such ADRs are rare, a case-control design is the only feasible approach, and a multi-centre international collaboration is necessary as no single country will generate enough cases of any given ADR within a reasonable time. I am delighted that the London School of Hygiene & Tropical Medicine is going to be playing a key role in a project that will greatly improve our understanding of genetic variation in relation to drug safety'.
London School of Hygiene & Tropical Medicine
Dr. Mariam Molokhia, Clinical Lecturer at the London School of Hygiene & Tropical Medicine, will be one of the main UK investigators of the collaborative project, and will be working jointly with SAEC to address clinical and scientific issues and identify DNA-variants useful in predicting the risk of drug-related serious adverse events, including liver toxicity and other series ADRs.
Dr. Molokhia co-ordinates the EUDRAGENE project, a European collaboration to establish a case-control DNA collection for studying the genetic basis of adverse drug reactions. She comments: 'Research in this area is hampered by a lack of resources. As most such ADRs are rare, a case-control design is the only feasible approach, and a multi-centre international collaboration is necessary as no single country will generate enough cases of any given ADR within a reasonable time. I am delighted that the London School of Hygiene & Tropical Medicine is going to be playing a key role in a project that will greatly improve our understanding of genetic variation in relation to drug safety'.
London School of Hygiene & Tropical Medicine
New study shows epidural during birth may negatively affect breastfeeding
Epidurals given during labour and birth are associated with decreased rates of breastfeeding, both in the short and long term.
Survey highlights 'crucial' safety issues in rhinitis treatment, particularly in children
Children may be at risk of receiving rhinitis treatment that suppresses growth - but the problem can be avoided through careful selection of treatment. This was the overwhelming message emerging from a recent nationwide survey of ENT specialists. According to the findings, the vast majority (91%) of specialists surveyed said they considered growth suppression the most important potential adverse drug reaction associated with nasal steroids. And a similar proportion (88%) said the selection of a nasal steroid for a child should be based on its low potential for adverse effects on growth. The use of systemic steroids has been linked to growth suppression but the danger is not necessarily avoid
More Adverse Drug Reaction Current Events and Adverse Drug Reaction News Articles
 | Adverse Drug Reactions Adverse reactions to medicines continue to present a considerable burden on healthcare, causing considerable morbidity and mortality. As well as knowing about the benefits of medicines, healthcare professionals need to understand the problem of adverse drug reactions and be aware of how they can be prevented and managed. The new edition of this essential and practical guide has been extensively... |
 | Stephens' Detection of New Adverse Drug Reactions A key text for all those involved in pharmacovigilance. Detection of new adverse drug reactions is fundamental to the protection of patients from harm that may occur as a result of medication. This book explores the methods used to investigate new adverse drug reactions, discussing all elements from the scientific background and animal toxicology through to worldwide regulatory and ethical... |
 | Adverse Drug Reactions: A Practical Guide to Diagnosis and Management Reviews the biochemical and physiological abnormalities in each of the body's organ systems, enabling investigators to decide if the problem is of drug-induced origin. Much of the material is presented as a series of observations with accompanying questions which should be addressed in order to make an accurate diagnosis. Includes useful flow charts for the management of adverse drug events and... |
 | Meyler's Side Effects of Drugs, Fifteenth Edition:The International Encyclopedia of Adverse Drug Reactions and Interactions 6 Volume Set(Meyler's Side Effects of Drugs) Building on the success of the 14 previous editions, this remarkable reference has been extensively reorganized and expanded and now comprises almost 1,500 individual drug articles providing the most complete coverage of adverse reactions and interactions found anywhere. Each article contains detailed and authoritative information about the adverse effects of each drug, with comprehensive... |
| Many adverse drug reactions seen after approval. (FDA Standards Questioned).: An article from: Family Practice News by Diana Mahoney This digital document is an article from Family Practice News, published by International Medical News Group on July 15, 2002. The length of the article is 601 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... | |
| Textbook of Adverse Drug Reactions (Oxford Medical Publications) by Andrew Davies Following the publication of its first edition, this book quickly established itself as an important, encyclopedic work. It provides a map to guide clinicians through the jungle of toxicological fact and theory presented by the mass of reports on adverse reactions to drugs published in a multitude of medical books and journals. Taking a unique approach to the subject, this completely updated... | |
 | Davies's Textbook of Adverse Drug Reactions by D.m. Davies, R.e. Ferner In recent years, a vast amount has been written on adverse drug reactions, yet this surfeit of information has made it more difficult for clinicians to obtain umambiguous answers to their questions. This book provides a "map" for clinicians to find their way through the jungle of tocicological fact and theory. Comprehensive yet succinct, the text deals with matters of fundamental importance, with... |
| Adverse Drug Reaction Terms - Definitions: Respiratory Disorders, Skin Disorders (Cioms Publication) by Who | |
 | Side Effects of Drugs Annual 28, Volume 28: A worldwide yearly survey of new data and trends in adverse drug reactions (Side Effects of Drugs Annual) Volume 28 in the series of Side Effects of Drugs Annuals (http://www.elsevier.com/locate/series/seda) continues to serve its primary goal: to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has reviewed new data and trends by selecting from... |
 | Side Effects of Drugs Annual 26, Volume 26: A world-wide yearly survey of new data and trends in adverse drug reactions (Side Effects of Drugs Annual) by Author Unknown The Side Effects of Drugs Annual was first published in 1977. It has been published continuously since then, as a yearly update to the encyclopaedic volume Meyler's Side Effects of Drugs. Each new Annual provides clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of... |
| © 2008 BrightSurf.com |